Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Zenalpha 0.5 mg Solution is a Health Canada–registered veterinary drug (DIN 02537648) held by Dechra Veterinary Products Inc., containing Medetomidine Hydrochloride. Health Canada lists its status as Marketed (status date 10 Jan 2024). Nexara Health has matched 4 registrations of Medetomidine Hydrochloride across 2 other regulated markets.

Health Canada registration

DIN02537648
Brand nameZenalpha
Active ingredientMedetomidine Hydrochloride
Strength0.5 mg
Dosage formSolution
RouteIntramuscular
CompanyDechra Veterinary Products Inc.
StatusMarketed — 10 Jan 2024
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Medetomidine Hydrochloride registered in other markets

4 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
PolandCepetor 1 mg/ml roztwór do wstrzykiwań dla psów i kotówCP-Pharma Handelsgesellschaft mbH1 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
PolandDomitor 1 mg/1 ml, roztwór do wstrzykiwań dla psów i kotówOrion Corporation1 mg/mlRoztwór do wstrzykiwańBezterminoweURPL RPL
United StatesMedetomidinePharmatory OyPowderFDA NDC
United StatesMedetomidine HydrochlorideInterquim, S.A. de C.V.PowderFDA NDC

See every manufacturer of Medetomidine Hydrochloride worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Zenalpha (DIN 02537648) marketed in Canada?

Yes. Health Canada lists DIN 02537648 as Marketed as of 10 Jan 2024.

Who holds the Canadian licence for this product?

Dechra Veterinary Products Inc. is the company of record in the Health Canada Drug Product Database.

Is Medetomidine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 4 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02537648, status date 2024-01-10; national medicine registries: FDA NDC, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02537648, status date 2024-01-10; national medicine registries: FDA NDC, URPL RPL.

Health Canada Drug Product Database (DPD), DIN 02537648, status date 2024-01-10; national medicine registries: FDA NDC, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.